Insider Shareholders with Direct Ownership of Apellis Pharmaceuticals, Inc. (APLS)
This section provides a comprehensive overview of the insiders with direct ownership of Apellis Pharmaceuticals, Inc. (APLS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Apellis Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Morningside Venture Investments Ltd
> 10% Shareholder |
250,000 | 0 | 12,806,342 $352 Million | 1 |
Nov 18, 2021
Added 1.91%
|
|
Cormorant Asset Management, Lp
> 10% Shareholder |
3,473,925 | 0 | 3,473,925 $95.4 Million | 1 |
Nov 13, 2017
Added 23.57%
|
|
Pascal Deschatelets
Chief Scientific Officer |
763,809 | 479,726 | 1,140,483 $31.3 Million | 74 |
May 20, 2024
Added 2.1%
|
|
Alec Machiels
Director |
183,967 | 72,750 | 370,761 $10.2 Million | 81 |
Jan 01, 2024
Added 0.89%
|
|
Cedric Francois
Chief Executive Officer |
1,396,489 | 1,790,906 | 313,662 $8.61 Million | 46 |
Mar 01, 2024
Reduced 0.13%
|
|
A. Sinclair Dunlop
Director |
164,020 | 11,894 | 152,126 $4.18 Million | 22 |
Sep 23, 2024
Added 2.94%
|
|
David O. Watson
General Counsel |
230,078 | 155,761 | 117,721 $3.23 Million | 39 |
Sep 27, 2024
Added 8.24%
|
|
Federico Grossi
Chief Medical Officer |
111,687 | 46,968 | 94,884 $2.6 Million | 56 |
Jan 05, 2023
Reduced 2.57%
|
|
Timothy Eugene Sullivan
Chief Financial Officer |
245,552 | 190,247 | 93,338 $2.56 Million | 31 |
Apr 01, 2024
Reduced 4.11%
|
|
Adam J. Townsend
Chief Commercial Officer |
289,048 | 228,746 | 92,453 $2.54 Million | 45 |
Feb 12, 2024
Reduced 1.23%
|
|
Lukas Scheibler
Chief Research Officer |
124,724 | 71,506 | 68,299 $1.87 Million | 30 |
Dec 01, 2023
Reduced 12.77%
|
|
Mark Jeffrey De Long
Chief Business & Strat Officer |
123,453 | 77,551 | 60,395 $1.66 Million | 44 |
Aug 12, 2024
Added 7.93%
|
|
Caroline Baumal
Chief Medical Officer |
60,994 | 2,751 | 58,376 $1.6 Million | 3 |
Jan 16, 2024
Added 30.36%
|
|
Jeffrey Eisele
Chief Development Officer |
85,486 | 28,278 | 57,208 $1.57 Million | 25 |
Jan 30, 2024
Reduced 1.67%
|
|
Nur Nicholson
Chief Technical Officer |
97,119 | 42,790 | 56,287 $1.55 Million | 16 |
Mar 13, 2024
Reduced 5.78%
|
|
Karen Lewis
Chief People Officer |
76,941 | 31,139 | 46,387 $1.27 Million | 23 |
Jan 30, 2024
Reduced 1.87%
|
|
James George Chopas
VP/Chief Accounting Officer |
39,933 | 5,475 | 38,141 $1.05 Million | 18 |
Sep 16, 2024
Reduced 0.5%
|
|
Victoria L. Brown
Program Team Lead |
36,598 | 17,157 | 23,556 $646,612 | 14 |
Jan 20, 2023
Reduced 5.66%
|
|
Paul R. Fonteyne
Director |
11,438 | 0 | 16,438 $451,223 | 3 |
Jan 01, 2024
Added 16.89%
|
|
Gerald Chan
Director |
11,438 | 0 | 11,438 $313,973 | 3 |
Jan 01, 2024
Added 22.61%
|
|
Stephanie Monaghan O'Brien
Director |
11,438 | 0 | 11,438 $313,973 | 3 |
Jan 01, 2024
Added 22.61%
|
|
Nicole D Perry
Vice President - Accounting |
32,500 | 30,153 | 4,847 $133,050 | 22 |
Aug 02, 2021
Reduced 17.1%
|